ReproCELL Incorporated
4978.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥2,979 | ¥2,427 | ¥2,953 | ¥2,235 |
| % Growth | 22.7% | -17.8% | 32.2% | – |
| Cost of Goods Sold | ¥1,332 | ¥1,306 | ¥1,812 | ¥1,431 |
| Gross Profit | ¥1,646 | ¥1,121 | ¥1,141 | ¥803 |
| % Margin | 55.3% | 46.2% | 38.6% | 36% |
| R&D Expenses | ¥537 | ¥385 | ¥502 | ¥535 |
| G&A Expenses | ¥1,243 | ¥1,145 | ¥996 | ¥915 |
| SG&A Expenses | ¥1,240 | ¥1,131 | ¥996 | ¥915 |
| Sales & Mktg Exp. | ¥0 | -¥14 | ¥0 | ¥0 |
| Other Operating Expenses | ¥0 | ¥14 | ¥0 | ¥0 |
| Operating Expenses | ¥1,777 | ¥1,530 | ¥1,497 | ¥1,451 |
| Operating Income | -¥130 | -¥409 | -¥356 | -¥647 |
| % Margin | -4.4% | -16.9% | -12.1% | -29% |
| Other Income/Exp. Net | ¥175 | ¥380 | ¥53 | ¥73 |
| Pre-Tax Income | ¥45 | -¥29 | -¥304 | -¥574 |
| Tax Expense | -¥58 | ¥3 | ¥2 | ¥1 |
| Net Income | ¥103 | -¥31 | -¥305 | -¥575 |
| % Margin | 3.5% | -1.3% | -10.3% | -25.7% |
| EPS | 1.11 | -0.37 | -3.62 | -7.57 |
| % Growth | 400% | 89.8% | 52.2% | – |
| EPS Diluted | 1.11 | -0.37 | -3.62 | -7.57 |
| Weighted Avg Shares Out | 93 | 85 | 84 | 76 |
| Weighted Avg Shares Out Dil | 93 | 86 | 84 | 76 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥67 | ¥51 | ¥43 | ¥9 |
| Interest Expense | ¥0 | ¥0 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥51 | ¥37 | ¥49 | ¥60 |
| EBITDA | ¥96 | ¥8 | -¥255 | -¥514 |
| % Margin | 3.2% | 0.3% | -8.6% | -23% |